Thursday, June 4, 2020
Neal D. Shore, MD, FACS Discusses Impact, Treatment Implications of the Phase III HERO Trial | Cancer Network
Neal D. Shore, MD, FACS Discusses Impact, Treatment Implications of the Phase III HERO Trial | Cancer Network: The Carolina Urologic Research Center expert discusses the benefits of oral relugolix for patients with prostate cancer.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment